z-logo
open-access-imgOpen Access
Uptake of Isoniazid Preventive Therapy among Under-Five Children: TB Contact Investigation as an Entry Point
Author(s) -
Yared Tadesse,
Nigussie Gebre,
Shallo Daba,
Zewdu Gashu,
Dereje Habte,
Nebiyu Hiruy,
Solomon Negash,
Kassahun Melkieneh,
Degu Jerene,
Yared Kebede Haile,
Yewulsew Kassie,
Muluken Melese,
Pedro Suarez
Publication year - 2016
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0155525
Subject(s) - medicine , isoniazid , tuberculosis , contact tracing , pediatrics , confidence interval , environmental health , disease , pathology , covid-19 , infectious disease (medical specialty)
A child’s risk of developing tuberculosis (TB) can be reduced by nearly 60% with administration of 6 months course of isoniazid preventive therapy (IPT). However, uptake of IPT by national TB programs is low, and IPT delivery is a challenge in many resource-limited high TB-burden settings. Routinely collected program data was analyzed to determine the coverage and outcome of implementation of IPT for eligible under-five year old children in 28 health facilities in two regions of Ethiopia. A total of 504 index smear-positive pulmonary TB (SS+) cases were reported between October 2013 and June 2014 in the 28 health facilities. There were 282 under-five children registered as household contacts of these SS+ TB index cases, accounting for 17.9% of all household contacts. Of these, 237 (84%) were screened for TB symptoms, and presumptive TB was identified in 16 (6.8%) children. TB was confirmed in 5 children, producing an overall yield of 2.11% (95% confidence interval, 0.76–4.08%). Of 221 children eligible for IPT, 64.3% (142) received IPT, 80.3% (114) of whom successfully completed six months of therapy. No child developed active TB while on IPT. Contact screening is a good entry point for delivery of IPT to at risk children and should be routine practice as recommended by the WHO despite the implementation challenges.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here